Murillo-Zamora E

Language: Spanish
References: 7
Page: 1-2
PDF size: 82.37 Kb.

Text Extraction

No abstract.

REFERENCES

1. International Agency for Research on Cancer.Age-Standardized Rate (World) per 100 000,Mortality, Males, in 2022. 2022.

2. Vromans RD, Tillier CN, Pauws SC, van derPoel HG, van de Poll-Franse LV, KrahmerEJ. Communication, perception, and use ofpersonalized side-effect risks in prostate cancertreatment-decision making: An observationaland interview study. Patient Education andCounseling. 2022;105(8): 2731–2739. https://doi.org/10.1016/j.pec.2022.04.017.

3. Balderas-Ortega J, Arellano-Romero NU,Vergara-Sánchez D. Perception of ProstateCancer in Mexican Men and Willingness forDigital Rectal Examination. Atención Familiar.2023;24(2): 87–92. https://doi.org/10.22201/fm.14058871p.2023.2.85025.

4. Hanna TP, King WD, Thibodeau S, Jalink M,Paulin GA, Harvey-Jones E, et al. Mortality dueto cancer treatment delay: systematic review andmeta-analysis. BMJ. 2020;371: m4087. https://doi.org/10.1136/bmj.m4087.

5. Basulto-Martínez M, Ojeda-Pérez JE, Velueta-Martínez IA, Cueto-Vega GJ, Flores-Tapia JP,González-Losa MDR. Prostate cancer earlydetection among primary care physicians inMexico: A cross-sectional study. Cirugia YCirujanos. 2021;89(2): 163–169. https://doi.org/10.24875/ciru.20000232.

6. Knaul FM, Doubova SV, Gonzalez Robledo MC,Durstine A, Pages GS, Casanova F, et al. Selfidentity,lived experiences, and challenges ofbreast, cervical, and prostate cancer survivorshipin Mexico: a qualitative study. BMC Cancer.2020;20(1): 577. https://doi.org/10.1186/s12885-020-07076-w.

7. Vázquez-Aguilar A, Rueda-Robles A, Rivas-García L, Vázquez-Lorente H, Duque-SotoCM, Jiménez-López KL, et al. Association ofDietary Patterns with Cardiovascular DiseaseRisk Factors in Mexican Adults: Insights froma Cross-Sectional Descriptive Study. Nutrients.2024;16(6): 804. https://doi.org/10.3390/nu16060804.